Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

13 results
Display

Medical Insurance Coverage for Diabetes Education

Kim K

The high prevalence, mortality and medical cost in diabetes mellitus raise the issue of diabetes management as one of the important component of social well-being. Self-management education for type 2...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Economic Evaluation of Diabetes Education

Noh JW, Kwon YD, Jung JH, Sim KH, Kim HS, Choi M, Park J

BACKGROUND: Diabetes education, also known as diabetes self-management training or diabetes selfmanagement education, is effective in helping patients with diabetes control their illness and maximize their health. However, there is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vaccination for Diabetic Patients: An Update

Yeom JS

As Korean populations are getting older and the number of adults with diabetes is continually increasing, importance of prevention of infectious diseases through vaccination has increased. With recent introduction of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Resolution of Type 2 Diabetes Mellitus Following Interferon-alpha Therapy for Chronic Hepatitis C

Park HS, Kim YJ, Moon SY, Woo JY, Choi JK, Kim KU, Park JR, Son HY, Kim DM

Hepatitis C virus (HCV) mainly affects the liver, but several tissues outside the liver have also been reported to be involved. It has been hypothesized that diabetes could be one...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Use of New Insulins and New Insulin Delivery Systems

Lim TS, Ko SH

Insulin plays an important role in the treatment of diabetes. Since it was discovered in the early 1920s, major advances have been made in the medical use of insulin. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter 2 Inhibitor

Jun JH, Choe KJ, Woo YM, Park YR, Park YK, Kim WJ, Shim MS, Kim JY

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral antihyperglycemic drugs; inhibition of the cotransporter allows for increased renal glucose excretion that consequently leads to reduced plasma glucose...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Application of Glucagon-Like Peptide-1 Receptor Agonists

Min SH, Cho YM

Glucagon-like peptide 1 (GLP-1) is an incretin hormone that is released from enteroendocrine L-cells upon nutrient absorption; it stimulates glucose-dependent insulin secretion from pancreatic betacells. GLP-1 has pleiotropic effects including...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy and Safety of Non-Nutritive Sweeteners

Ju DL

High intake of added sugars increases the risk for obesity, type 2 diabetes, and cardiovascular disease. Non-nutritive sweeteners (NNS) are widely used in many beverages and food products to reduce...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent Advances for Anti-Obesity Agents

Kim CS

Obesity is one of the most significant risk factor for diabetes, cardiovascular disease, malignancy and other chronic diseases. The obesity and its associated conditions is one of the most urgent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How Digital Technology Will Contribute to Future Innovations in Healthcare

Choi YS

Digital technology is dramatically transforming today's healthcare. Over the past decade, exponential advances in digital technology, especially in smart phones, have radically changed many aspects of everyday life. Medicine will...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Narrative Therapy for Diabetic Patients

Koo MH

Diabetic patients undergo psychosocial difficulties, including anger, because of their chronic disease, anxiousness of complications, and stress resulting from the need for self-management. These difficulties often lead to depression and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Update on the Pharmacologic Agents for Dyslipidemia

Lee SH

Although statins have demonstrated consistent and strong effects on cardiovascular prevention, non-statin drugs have failed to show additional clinical benefit. Consequently, statins are currently recommended as first-line therapy in dyslipidemia....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Vildagliptin on Visfatin in Korean Patients with Type 2 Diabetes: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Prospective Study

Jang YH, In DH, Yang JK, Moon HJ, Yoon GT, Ryu AJ, Kim YJ, Lee EY, Kim HJ, Ku BJ, Lee JM, Park KS, Lee IS, Lee JM, Lim DM, Park KY, Kim SJ

BACKGROUND: The effects of dipeptidyl peptidase-4 inhibitors on adipokines remain obscure. The aim of this study was to evaluate the effect of the addition of vildagliptin on visfatin, an adipokine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr